A Study to Characterize the Disease Behavior of Idiopathic Pulmonary Fibrosis (IPF) and Interstitial Lung Disease (ILD) During the Peri-Diagnostic Period

NCT03261037 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

178

Enrollment

INDUSTRY

Sponsor class

Conditions

Idiopathic Pulmonary Fibrosis
Interstitial Lung Disease

Interventions

OTHER: Spirometry
OTHER: Accelerometry
OTHER: 6MWT

Sponsor

Hoffmann-La Roche